Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumorsAmanda Nash, Omid Veiseh, Maria Jarvis et al.|Science Advances|2022Cited by 81
IL-12-producing cytokine factories induce precursor exhausted T cells and elimination of primary and metastatic tumorsAmanda Nash, Omid Veiseh, Nathan E. Reticker-Flynn et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 10
Uncovering the interleukin‐12 pharmacokinetic desensitization mechanism and its consequences with mathematical modelingJonathon DeBonis, Oleg A. Igoshin, Omid Veiseh|CPT Pharmacometrics & Systems Pharmacology|2024Cited by 5
Factors influencing monoclonal antibody pharmacokinetics across varying immune perturbationsJonathon DeBonis, Omid Veiseh, Zeshi Wang et al.|Journal of Controlled Release|2025Cited by 4
Uncovering the Interleukin-12 Pharmacokinetic Desensitization Mechanism and Its Consequences with Mathematical ModelingJonathon DeBonis, Oleg A. Igoshin, Omid Veiseh|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1